Medicine and Dentistry
Visual Acuity
94%
Retinal Detachment
85%
Vitrectomy
68%
Cataract Surgery
51%
Silicone Oil
43%
Pars Plana Vitrectomy
42%
Macular Hole
36%
Age Related Macular Degeneration
34%
Bevacizumab
30%
Injury
30%
Optical Coherence Tomography
28%
Eye Injury
27%
Bleeding
26%
Retinopexy
24%
Telangiectasia
23%
Phacoemulsification
23%
Cataract
22%
Intraocular Lens Implantation
22%
Endophthalmitis
19%
Diabetic Macular Edema
19%
Extracapsular Cataract Extraction
19%
Epiretinal Membrane
18%
Intraocular Lens
18%
Surgery
18%
Subretinal Fluid
16%
Photodynamic Therapy
15%
Glaucoma
15%
Intravitreal Administration
14%
Central Retinal Vein Occlusion
14%
Vein Occlusion
13%
Vasculotropin
12%
Diabetic Retinopathy
11%
Arteritic Anterior Ischemic Optic Neuropathy
11%
Central Serous Retinopathy
11%
Choroidal Neovascularization
11%
Central Retinal Artery Occlusion
11%
Antithrombotic
11%
Indocyanine Green
11%
Scleral Buckle
11%
Surgical Technique
11%
Anterior Chamber of Eyeball
11%
Indocyanine Green Angiography
10%
Retina Tear
10%
Intraocular Foreign Body
10%
Retinal Pigment Epithelium
9%
Diabetes Mellitus
9%
Prognostic Factor
9%
Cardiac Tamponade
9%
Intraocular Pressure
9%
Incision
9%
Keyphrases
Visual Acuity
100%
Pars Plana Vitrectomy
44%
Vitrectomy
43%
Age-related Macular Degeneration
39%
Rhegmatogenous Retinal Detachment
39%
Bevacizumab
33%
Macular Hole
32%
Cataract Extraction
30%
Silicone Oil
27%
Retinal Detachment
26%
Diabetic Macular Edema
25%
Pneumatic Retinopexy
24%
Intravitreal Ranibizumab
24%
Intraocular Lens Implantation
22%
Optical Coherence Tomography
21%
Retinal Vein Occlusion
20%
Extracapsular Cataract Extraction
20%
Neovascular Age-related Macular Degeneration (nAMD)
19%
Phacoemulsification
17%
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
17%
Visual Outcome
17%
Polymorphism
16%
Silicone Injection
16%
Endophthalmitis
15%
Recurrent Retinal Detachment
15%
Internal Limiting Membrane Peeling
15%
Cataract Surgery
15%
Risk Factors
14%
Subretinal Fluid
14%
Glaucoma
14%
Retinal Thickness
13%
Anatomic Success
13%
Retina
13%
Ranibizumab
12%
Functional Outcome
12%
Vitreoretinal Surgery
12%
Epiretinal Membrane
12%
Consecutive Patients
12%
Additional Surgery
11%
Open Globe Injury
11%
Photodynamic Therapy
11%
Central Serous Chorioretinopathy
11%
Posttraumatic Stress Disorder
11%
Risk Assessment
11%
Central Retinal Artery Occlusion
11%
Branch Retinal Vein Occlusion
11%
Surgical Outcomes
11%
Indocyanine Green
11%
Scleral Buckle
11%
Macular Telangiectasia Type 2
11%